Copy
View this email in your browser
Vol. 3, No. 10                                                                                                          May 20, 2020

Cancer Institute Member Spotlight

Samuel Mackintosh, Ph.D.
Assistant Professor
Department of Biochemistry and Molecular Biology
UAMS College of Medicine
Co-Director, Winthrop P. Rockefeller Cancer Institute Proteomics Shared Resource and UAMS Proteomics Core Facility
 
Dr. Mackintosh's research interests are focused on proteomics and mass spectrometry. As co-director of the  Winthrop P. Rockfeller Cancer Institute Proteomics Shared Resource and UAMS Proteomics Core Facility, he is involved in a wide variety of basic and translational research projects and collaborations at any given time. Read more>
Register now for American Cancer Society Extramural Grants Program Webinar
Arkansas INBRE Receives 5-Year
Funding of $18.4 Million to Promote
Biomedical Research Across Arkansas
Students in the 2019 INBRE Summer Research Program worked in labs at UAMS.

Arkansas INBRE, which promotes biomedical research with programs for undergraduate students and faculty statewide, has seen its federal funding renewed for $18.4 million over the next five years.

“Under the leadership of Dr. Larry Cornett, the Arkansas INBRE has supported the growth of science across Arkansas for more than two decades, including significant investment into student training, bioinformatics and core resources that have fueled the growth of the Winthrop P. Rockefeller Cancer Institute and better positioned us to become an NCI-Designated Cancer Center” said Alan Tackett, Ph.D., associate director for basic research in the Cancer Institute. Read more>

Cancer-related Research Funding Opportunities
Extramural Opportunities

Notice of Special Interest (NOSI): Administrative Supplement to a Cancer Moonshot Coordinating Center (U24) to Support the Mechanisms of Cancer Drug Resistance and Sensitivity Network (DSRN)

Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)  

Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)

NOSI: Administrative Supplements for Development of Risk-stratified Cancer Survivorship Care Algorithms

Integrating Biospecimen Science Approaches into Clinical Assay Development

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

DoD Lung Cancer, Concept Award

DoD Lung Cancer, Career Development Award
 
DoD Lung Cancer, Investigator-Initiated Translational Research Award

DoD Lung Cancer, Clinical Translational Research Partnership Award
 
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)

DOD Prostate Cancer, Early Investigator Research Award

DoD Prostate Cancer, Health Disparity Research Award

DoD Prostate Cancer, Clinical Trial Award

DoD Prostate Cancer, Translational Science Award

DoD Prostate Cancer, Population Science and Outcomes Research Award

DoD Prostate Cancer, Idea Development Award

DoD Prostate Cancer, Prostate Cancer Pathology Resource Network Award

DoD Prostate Cancer, Physician Research Award

Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

DoD Neurofibromatosis, Investigator-Initiated Research Award

DoD Neurofibromatosis, Clinical Trial Award

DoD Neurofibromatosis, Exploration – Hypothesis Development Award

DoD Neurofibromatosis, New Investigator Award

DoD Neurofibromatosis, Early Investigator Research Award

DoD Neurofibromatosis, Synergistic Idea Award

DoD, Breast Cancer, Breakthrough Award Levels 1 and 2

DoD, Breast Cancer, Breakthrough Award Level 3

DoD, Breast Cancer, Breakthrough Award Level 4

DoD, Breast Cancer, Innovator Award

DoD Breast Cancer, Era of Hope Scholar Award

DoD Breast Cancer, Transformative Breast Cancer Consortium Award

DoD Melanoma Research Program, Idea Award

DoD Melanoma Research Program, Mid-Career Accelerator Award

DoD Melanoma Research Program, Team Science Award

DoD Melanoma Research Program, Technology Development Partnership Award

DoD Melanoma Research Program, Translational Research Award

DoD Melanoma Research Program, Translational Research Award – Collaborator Option

DoD CDMRP Ovarian Cancer Research Program Ovarian Cancer Academy – Early-Career Investigator Award

DoD CDMRP Ovarian Cancer Research Program Clinical Translational Research Award

DoD CDMRP Ovarian Cancer Research Program Pilot Award

DoD CDMRP Ovarian Cancer Research Program Investigator-Initiated Research Award
 
DoD CDMRP Ovarian Cancer Proteogenomics Research Award

DoD Academy of Kidney Cancer Investigators – Early Career Investigator Award

DoD Kidney Cancer Research Program Concept Award

DoD Kidney Cancer Research Program Translational Research Partnership Award

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01)

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

NIH Utilizing Cohort Studies to Address Outcomes in Cancer Survivors
 
CTSA Supplemental Funding Opportunities

NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
 
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)

 
Foundation and Intramural Funding Opportunities

Mark Foundation Emerging Leader Awards

When Everyone Survives Leukemia Research Foundation Grant Application
 
Know someone who needs to be added to our email list? Send their name to Susan Van Dusen, communications manager.
Copyright © 2021 *|LIST:COMPANY|*, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp